UFP Technologies Inc (UFPT)
Other Materials • Basic Materials
July 29, 2026 UFP Technologies Inc. to Announce Second Quarter Financial Results UFP Technologies, Inc. will report its second quarter financial results on August 3, 2026, followed by a conference call on August 4. The company specializes in medical devices and continues to impact the healthcare sector significantly.
July 01, 2026 UFP Technologies Inc. to Showcase Growth Potential at CJS Securities Conference UFP Technologies, Inc. will showcase its growth potential at the CJS Securities Conference on July 9, 2026. The company’s leadership will discuss innovations in medical devices and engage with investors to share strategic insights.
June 04, 2026 UFP Technologies to Showcase Growth Potential at 16th Annual East Coast IDEAS Investor Conference UFP Technologies will present at the 16th Annual East Coast IDEAS Investor Conference on June 10, 2026, showcasing its growth potential in the medical device sector. The presentation will focus on the company's strategic direction and innovative solutions catering to healthcare needs.
June 04, 2026 UFP Technologies Appoints Ryan Stafford as General Counsel and Senior VP of Human Resources UFP Technologies appoints Ryan Stafford as General Counsel and Senior VP of HR, succeeding Chris Litterio. Stafford's extensive experience in legal and HR roles positions him to guide UFP's growth strategy in the medical device sector.
May 04, 2026 UFP Technologies Reports Strong Q1 Results for 2026 UFP Technologies announced strong Q1 2026 results, with a 4.1% increase in net sales to $154.2 million. The company is strategically pivoting towards the MedTech sector, emphasizing growth in robotic surgery and safe patient handling.
April 30, 2026 UFP Technologies Set to Release First Quarter 2026 Financial Results UFP Technologies is set to release its Q1 2026 financial results on May 4, followed by a conference call on May 5. Analysts are eager to assess the company's performance in the evolving medical device sector.
March 17, 2026 UFP Technologies Set to Engage Investors at KeyBanc Capital Markets Virtual Healthcare Forum UFP Technologies will participate in the KeyBanc Capital Markets Virtual Healthcare Forum on March 18, 2026, where executives will discuss the company's direction and growth. With a focus on medical device innovation, UFP aims to strengthen investor relations and highlight its role in the healthcare supply chain.
February 27, 2026 UFP Technologies to Showcase Growth and Innovation at Raymond James Conference UFP Technologies will showcase its growth and innovation at the Raymond James Conference, highlighting its role in medical device manufacturing and its strategic vision. CEO R. Jeffrey Bailly and CFO Ron Lataille will lead the presentation, emphasizing the company's impact on healthcare.
February 27, 2026 UFP Technologies Inc. Reports Strong Financial Performance for 2025 UFP Technologies Inc. reported a 19.5% increase in net sales for 2025, reaching $602.8 million, largely due to a surge in medical market sales. Despite facing operational challenges, including labor issues, the company's financial resilience and growth strategies position it well for the future.
February 24, 2026 UFP Technologies Reports Record Results for 2025 UFP Technologies reported a 15.8% increase in net income for 2025, reaching $68.3 million, driven by a robust 19.5% rise in net sales. Despite facing labor inefficiencies, the company remains optimistic about future growth and strategic expansion in the medical sector.
February 19, 2026 UFP Technologies Set to Unveil Fourth Quarter and Year-End 2025 Financial Results UFP Technologies is set to announce its financial results for Q4 and Year-End 2025 on February 24, 2026, followed by a conference call on February 25. This report is crucial for investors and analysts as it reflects the company's performance in the evolving medical device landscape.
December 02, 2025 UFP Technologies Announces CEO Succession Plan: A New Chapter for the Medical Device Leader UFP Technologies announces that CEO R. Jeffrey Bailly will retire in June 2026, with Mitchell Rock set to take over the leadership role. Bailly's 31-year tenure saw significant growth, and Rock aims to build on this legacy.
November 25, 2025 UFP Technologies Set to Showcase Innovations at the Piper Sandler Healthcare Conference UFP Technologies will present its latest innovations at the Piper Sandler Healthcare Conference on December 3, 2025. The company's leadership will share insights on strategic initiatives and product offerings in medical device manufacturing, emphasizing their role in minimally invasive surgery and infection prevention.
November 07, 2025 UFP Technologies Inc. Reports Strong Q3 Results Amid Challenges UFP Technologies Inc. reported strong financial results for Q3 2025, with a 6.5% increase in net sales driven by the medical market. Despite labor challenges and tariff impacts, strategic acquisitions and robust operational cash flow support the company's growth trajectory.
November 03, 2025 UFP Technologies Reports Strong Q3 2025 Results Amid Strategic Growth Initiatives UFP Technologies, Inc. reported strong Q3 2025 results with $154.6 million in sales and a net income of $16.4 million. The company emphasizes its strategic growth initiatives, including operational improvements and successful acquisitions, positioning itself for sustained growth in the medical device sector.
October 29, 2025 UFP Technologies Set to Release Third Quarter Financial Results UFP Technologies is set to release its Q3 financial results on November 3, 2025, with a follow-up conference call on November 4. Investors are eager for insights on the company’s performance in the evolving healthcare landscape.
August 11, 2025 UFP Technologies Inc. Reports Impressive Q2 2025 Results UFP Technologies Inc. reported impressive Q2 2025 results, showcasing a 37.2% rise in net sales, primarily driven by growth in the medical market. Despite challenges in costs, the company remains optimistic about future expansion and strategic acquisitions.
May 12, 2025 UFP Technologies Inc. Reports Strong Q1 2025 Results UFP Technologies, Inc. achieved a remarkable 41.1% increase in net sales in Q1 2025, primarily fueled by a surge in the medical market. Despite some challenges in cost management and operational efficiency, the company's strategic acquisitions position it well for future growth.
March 17, 2025 UFP Technologies to Showcase Innovations at KeyBanc Capital Healthcare Forum UFP Technologies will showcase its innovations in medical device manufacturing at the KeyBanc Capital Markets Healthcare Forum on March 18, 2025. CEO R. Jeffrey Bailly and CFO Ron Lataille will discuss the company's growth strategies and market position, highlighting its role in the healthcare supply chain.
March 03, 2025 UFP Technologies Inc. Reports Impressive Growth in 2024 Annual Report UFP Technologies Inc. reported a remarkable 26.1% increase in net sales for 2024, driven largely by the medical sector. The company's strategic acquisitions and commitment to innovation have significantly enhanced its market position and financial performance.
February 25, 2025 UFP Technologies Reports Record Results for 2024 UFP Technologies reported a record net income of $59 million for 2024, a 31.3% increase from the previous year, driven by significant sales growth and strategic acquisitions. The company is expanding operations to meet rising demand, particularly in the medical device market, and is optimistic about future growth opportunities.
February 19, 2025 UFP Technologies to Report Fourth Quarter and Year-End 2024 Results UFP Technologies is set to release its financial results for Q4 and the full year 2024 on February 25, 2025. This report will highlight the company's growth and strategies in the medical device supply chain, a critical sector amid evolving healthcare challenges.
February 06, 2025 SWOT Analysis of UFP Technologies Inc. in 2025 This SWOT analysis evaluates UFP Technologies Inc., highlighting its robust reputation and operational strengths while addressing risks like customer concentration and competition. The company has growth opportunities in the MedTech market and must navigate regulatory and cybersecurity threats to ensure sustained success.
November 12, 2024 UFP Technologies Inc. Reports Strong Q3 2024 Results Amid Strategic Acquisitions UFP Technologies Inc. reported a significant 44% increase in net sales for Q3 2024, driven by strategic acquisitions and a rise in the medical market. The company also saw improved profit margins, despite increased expenses from recent acquisitions, positioning itself for future growth in the medical device sector.
August 09, 2024 UFP Technologies Inc. Reports Strong Q2 Results for 2024 UFP Technologies Inc. reported a 10.1% increase in Q2 2024 sales, reaching $110.2 million, with net income rising to $14.3 million. Strategic acquisitions and a strong market presence position the company for continued growth in the medical device sector.
May 10, 2024 UFP Technologies Inc. Reports Impressive Q1 2024 Results UFP Technologies Inc. reported impressive Q1 2024 results with a 7.4% increase in net sales to $105 million and a net income rise to $12.7 million. Despite a slight decline in gross margins, strong demand in medical and aerospace segments propels future growth prospects.